customer login
InoveonIfa Systems AG

The Inoveon System

Now, target patients for early intervention and deliver a new dimension of diabetic eye care.

Inoveon's turn-key system is the proven solution for the detection, staging, monitoring, and treatment of diabetic retinopathy and macular edema.

read more

Detetction, monitoring, and therapy  together in one service.

Inoveon works with board-certified retinal specialists to triage and treat patients needing a range of standard sight-preserving treatments for diabetic retinopathy and macular edema - all included.

Take control of your budget and cap costs with our integrated therapy.

read more

In the U.S. 24 million persons are afflicted with diabetes, 57 million have pre-diabetes (1), and by 2030 global prevalence of diabetes is expected to double. (2)

(1) American Telemedicine Association Telehealth Practice Recommendations for Diabetic Retinopathy. (2)

Diabetic Retinopathy is the leading cause of preventable blindness in the adult working-aged population. However, treatments for DR are extremely effective if delivered at the right time in the disease process.